Bayforest Capital Ltd Boosts Holdings in Humana Inc. $HUM

Key Points

• Bayforest Capital Ltd significantly increased its stake in Humana Inc. by 803.1%, owning 4,416 shares valued at approximately $1.17 million, which represents 0.5% of its portfolio.
• Humana recently declared a quarterly dividend of $0.885, resulting in an annualized yield of 1.1%, and its payout ratio stands at 27.17%.
• The stock has a market capitalization of $37.33 billion, with a 1-year trading range between $206.87 and $357.00.

Bayforest Capital Ltd increased its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 803.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,416 shares of the insurance provider's stock after buying an additional 3,927 shares during the quarter. Humana accounts for 0.5% of Bayforest Capital Ltd's portfolio, making the stock its 20th biggest holding. Bayforest Capital Ltd's holdings in Humana were worth $1,168,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently modified their holdings of the company. Janney Montgomery Scott LLC acquired a new position in Humana during the 1st quarter worth $1,309,000. Envestnet Asset Management Inc. increased its holdings in Humana by 2.4% during the 1st quarter. Envestnet Asset Management Inc. now owns 125,684 shares of the insurance provider's stock worth $33,256,000 after purchasing an additional 2,950 shares in the last quarter. Circle Wealth Management LLC bought a new position in Humana during the 1st quarter worth about $425,000. Rhumbline Advisers increased its holdings in Humana by 3.3% during the 1st quarter. Rhumbline Advisers now owns 246,037 shares of the insurance provider's stock worth $65,101,000 after purchasing an additional 7,909 shares in the last quarter. Finally, Arizona State Retirement System boosted its stake in shares of Humana by 3.4% during the 1st quarter. Arizona State Retirement System now owns 35,337 shares of the insurance provider's stock worth $9,350,000 after buying an additional 1,165 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on HUM. Truist Financial cut their target price on shares of Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research note on Wednesday, July 16th. Wall Street Zen cut shares of Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Sanford C. Bernstein lifted their price objective on shares of Humana from $269.00 to $341.00 and gave the company an "outperform" rating in a research note on Friday, September 5th. Bank of America raised their target price on shares of Humana from $285.00 to $312.00 and gave the company a "neutral" rating in a research report on Tuesday, September 2nd. Finally, Piper Sandler dropped their price target on Humana from $288.00 to $272.00 and set a "neutral" rating for the company in a research note on Thursday, July 31st. Seven investment analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $289.24.

Humana Stock Down 0.8%

Shares of NYSE:HUM traded down $2.36 during midday trading on Friday, hitting $276.36. 1,138,341 shares of the company's stock were exchanged, compared to its average volume of 1,648,760. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $325.75. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The stock has a 50 day moving average price of $265.34 and a 200-day moving average price of $257.18. The company has a market cap of $33.24 billion, a PE ratio of 21.21, a price-to-earnings-growth ratio of 1.64 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The firm had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The company's revenue for the quarter was up 9.6% on a year-over-year basis. During the same period in the previous year, the company posted $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. On average, sell-side analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date of this dividend is Friday, September 26th. Humana's dividend payout ratio is 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.